Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug composition and method for preparing the same

A composition and medicine technology, applied in the field of pharmaceutical compositions and their preparation methods, can solve the problems of poor coating rate, drug leakage, complicated manufacturing process and the like

Active Publication Date: 2017-02-15
SPRING FOUND OF NCTU
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, coating the two drugs with multiple shells is prone to problems such as drug leakage, poor coating rate, and complicated manufacturing process.
In addition, if it is desired to coat drugs by polymer self-assembly, it is difficult to coat both hydrophilic and hydrophobic drugs
[0004] Therefore, how to solve the known process problem that multiple steps and multiple environments are required for coating multiple drugs on nanoparticles, and provide a single step to coat hydrophilic and hydrophobic drugs at the same time to prepare drug-loaded particles is really an important step. an important topic

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug composition and method for preparing the same
  • Drug composition and method for preparing the same
  • Drug composition and method for preparing the same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Embodiment 1: Preparation of amphiphilic chitosan derivatives modified by hydrophobic hexanoyl group and hydrophilic carboxylic acid

[0041] First, 5 grams (g) of chitosan (Mw = 215,000 g / mol, 80 to 90% deacetylation, purchased from Adrich-Sigma) was suspended in isopropanol (50 milliliters (mL)) at room temperature , and stirred for 30 minutes. The resulting suspension was slowly mixed with aqueous sodium hydroxide solution (12.5 mL) to obtain a mixed solution, and the amount of grafted hydrophilic functional groups could be controlled by adjusting the concentration of sodium hydroxide in the mixed solution. Here, the mixed solution contained 13.3M sodium hydroxide. Next, the mixed solution was reacted with chloroacetic acid to prepare water-soluble hydrophilic carboxymethyl-modified chitosan, and dried.

[0042] 2 g of dried hydrophilic carboxyformic acid-modified chitosan was dissolved in pure water (50 mL), and stirred for 24 hours. Next, the obtained solution w...

Embodiment 2

[0044] Example 2 Encapsulation of Drugs Using Amphiphilic Chitosan Derivatives

[0045] Take by weighing the amphiphilic chitosan powder prepared in Example 1 of 0.5 milligrams (mg), add 200 microliters (μ L) of 0.1% deoxymethyl curcumin (dissolved in methanol), and utilize a shaker to mix slightly Finally, add 540 μL of double distilled water, then add 60 μL of pH 10.5 double distilled water, finally add 200 μL of 0.1% cisplatin (cisplatin) (dissolved in water), and stir for 12 hours to prepare the coated double drug (containing deoxymethylcurcumin and cisplatin) nanoparticles.

Embodiment 3

[0046] Example 3 Coating rate test of nanoparticles coated with double drugs

[0047] Put the synthesized double-drug coated nanoparticles into a concentrating centrifuge tube, and centrifuge at 4000 rpm for 30 minutes.

[0048] (1). Cisplatin coverage

[0049] Dilute the supernatant of the concentrated centrifuge tube by 20 times, mix it with 0.14% o-phenylenediamine in dimethylformamide solution at a ratio of 1:1, heat at 100°C for 30 minutes, and put it in a -20°C refrigerator for 10 minutes After cooling, the solution is finally detected by UV-visible light at the peak at a wavelength of 705nm. After conversion, the uncoated cisplatin content is obtained, and then the cisplatin coating rate is obtained.

[0050] (2). Deoxymethyl curcumin coating rate test

[0051] The nanoparticles on the filter membrane of the concentrated centrifuge tube were redissolved with twice distilled water, and the solution was mixed with methanol at a ratio of 1:1, and analyzed by HPLC. C18 i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle diameteraaaaaaaaaa
Login to View More

Abstract

The present invention provides a drug composition and a method for preparing the drug composition, which includes steps of dispersing an amphiphilic chitosan derivative, at least a hydrophobic drug, and at least a hydrophilic drug into a solvent to form a mixture solution, and the pH value of the mixture solution is adjusted to a range without precipitating the hydrophilic drug(s) and the hydrophobic drug(s), wherein the amphiphilic chitosan derivative is modified by a plurality of hydrophilic group(s) and a plurality of hydrophobic group(s); and after stirring the mixture solution for at least 12 hours, receiving the drug composition when the pH value of the mixture solution is between pH 6 to 7. The hydrophilic drug(s) and the hydrophobic drug(s) are encapsulated simultaneously by one-pot synthesis, and the protein could be modified by one-pot synthesis to provide a drug composition with multiple functions.

Description

technical field [0001] The present invention relates to a pharmaceutical composition and a preparation method thereof, in particular to a pharmaceutical composition in which hydrophobic drugs and hydrophilic drugs are coated with amphiphilic chitosan and a preparation method thereof. Background technique [0002] Chitin is widely distributed in nature. In addition to crustaceans (such as shrimp, crab, and insect shells), it also includes microorganisms (bacterial cell walls or mushrooms) and algae in the plant kingdom. . Chitosan (chitosan) [poly (β-1,4-glucosamine)] [poly (β-1,4-glucosamine)], also known as chitosan, is made of chitin through different degrees of deacetylation reaction resulting heterogeneous aggregates. Chitosan is a copolymer of N-acetylglucosamine and N-glucosamine as structural units, and the content of N-glucosamine structural units in the polymer is usually higher than 60%. Due to chitosan's good biocompatibility (biocompatibility), non-toxicity, b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/51A61K47/36A61K47/42A61K49/00A61K33/24A61P35/00A61K31/12A61K33/243
CPCA61K47/36A61K47/6857A61K47/6939A61K9/5161A61P35/00A61P43/00A61K33/243A61K31/12
Inventor 黄唯婷李翊绮刘典谟
Owner SPRING FOUND OF NCTU
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com